What is the SPRINT research treatment algorithm for the intensive group?
At randomization visit, begin with 2- or 3-drug therapy using a combination of a thiazide-type diuretic, and/or an ACEI or ARB (but not both) and/or a CCB Include -blocker or other agents as appropriate for compelling indication. Monitor as designated through follow-up. If SBP is 120 mm Hg this visit or DBP is 100 mm Hg at this visit or DBP is 90 mm Hg on last two visits, then add therapy not already in use and see participant monthly until SBP <120 mm Hg. If this is not a milepost visit, then titrate or add therapy not already in use and continue therapy.